(Q43754303)

26 November 2017

title

The EBMT activity survey 2008: impact of team size, team density and new trends (English)

1 reference

26 November 2017

A Gratwohl

1

1 reference

26 November 2017

H Baldomero

2

1 reference

26 November 2017

A Schwendener

3

1 reference

26 November 2017

M Gratwohl

4

1 reference

26 November 2017

J Apperley

5

1 reference

26 November 2017

K Frauendorfer

6

1 reference

26 November 2017

D Niederwieser

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

29 March 2010

1 reference

Bone Marrow Transplantation

26 November 2017

published in

1 reference

26 November 2017

volume

46

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

174-191

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.69

26 November 2017

exact match

0 references

cites work

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Hematopoietic-cell transplantation at 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Predictability of hematopoietic stem cell transplantation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Stem cell transplantation for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Cord blood transplantation: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

UK Renal Registry 11th Annual Report (December 2008): Chapter 5 Demographics and biochemistry profile of kidney transplant recipients in the UK in 2007: national and centre-specific analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

The frequency and outcome of biliary atresia in the UK and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

Current trends in hematopoietic stem cell transplantation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

7 January 2021

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

7 January 2021

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

7 January 2021

Aplastic anemia: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

7 January 2021

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

7 January 2021

[JACIE: from guidelines to clinical practice and continuous quality improvement, the Léon-Bérard cancer center experience].

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.69

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.69

1 reference

Dimensions Publication ID

26 November 2017

1007837004

0 references

1 reference